E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Diseases > What is Herpes 1 and How Is It Diagnosed & Treated?

Tags

  • while
  • children
  • their
  • developing combination
  • developing combination
  • combination products

  • Links

  • The Simple Way to Make a lot of Money from Google Adwords
  • Essential Fatty Acids Can Help With Attention Defict
  • 7 Steps to Lose Weight and Keep it Off
  • E-Articles - What is Herpes 1 and How Is It Diagnosed & Treated?

    The herpes 1 virus, which is often abbreviated HSV-1, is the most common cause of oral herpes. Those who have contracted the affliction become susceptible to recurring c
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    old sores that are often seen on people’s lips or around their mouths. Some studies have reported that up to 80% of the American population has this form of the herpe
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    s virus present in their system.

    The condition is often contracted as a child, and active outbreaks are most common in children. The herpes type 1 virus can be easi
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ly transmitted between children. The viral elements are strongest in the actual sores that develop, and direct contact with these sores can result in a transfer of th
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    virus, but transmission in also possible when contaminated saliva is passed on. In childhood, the sharing of toys, and the fact that it is not uncommon for children
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    to come in contact with each other while playing, makes it difficult to develop a foolproof prevention method.

    From the start of the first outbreak, the human body begi
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ns to form antibodies against the virus. The herpes virus can become dormant in a person after a significant amount of antibodies have been formed. This dormancy can co
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    tinue for lengthy amounts of time, often resulting in monthly and yearly periods where there are no indications of an outbreak. By the time a child with herpes simplex o
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ne has reached adulthood, the antibodies have usually built up enough to prevent outbreaks from developing at all. It is possible to contract herpes 1 as an adult
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    , though it is uncommon.

    Genital herpes can develop as a result of contracting herpes type 1, although it occurs far less frequently than the oral manifestation of the v
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    rus. The most common method of transmitting the genital variation to another person is through oral sex. When the virus produces an active outbreak in a person’s mouth
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    or on their lips, contact between the infected area and the genitals has the potential to produce genital herpes in the sexual partner of the person with herpes 1. Once
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    a person has contracted genital herpes as a result of HSV-1, they can then spread the virus to the genitals of later sexual partners. It is more common, however, for
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    >most incidences of genital herpes to be caused as a result of the herpes 2 virus. In order to prevent the transmission to the genitals, condoms or dental dams shoul
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    be used when an infected person engages in any kind of sexual contact.

    It is not known exactly what triggers the onset of the Herpes simplex one outbreaks. Most doctor
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    s and researchers have agreed that various forms of stress, such as facial injury, sunburns, trauma, and surgery, are the most common contributing factors to outbreaks.
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    The presences of additional temporary viral infections, particularly those that dwell in the respiratory system, have also resulted in the formation of outbreaks. It has
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    been confirmed, however, that people with weak immune systems often suffer from herpes 1 outbreaks m
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ore often than those with stronger immune systems.

    Once a person contracts herpes type 1, they have the virus within their bodies for the remainder of their lives. Ther
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e are no known cures for the condition, but it can be easily treated. Both prescription and natural remedies are available to aid in the treatment of the symptoms


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/241479/e-article-What-is-Herpes-1-and-How-Is-It-Diagnosed--Treated.html">What is Herpes 1 and How Is It Diagnosed & Treated?</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/241479/e-article-What-is-Herpes-1-and-How-Is-It-Diagnosed--Treated.html]What is Herpes 1 and How Is It Diagnosed & Treated?[/url]

    Related Articles:

    CCTV, Video Surveillance, and Security Cameras: A Buyer's Guide

    Top 7 Steps to Protect your Computer from Hurricanes

    No Clips? No Problem!

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com